Suchergebnisse

Altimmune ALT incurred a second-quarter 2026 loss of 12 cents per share, narrower than the Zacks Consensus Estimate of a loss of 15 cents. The company had recorded a loss of 27 cents per share in

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the

In its upcoming report, Viking Holdings (VIK) is predicted by Wall Street analysts to post quarterly earnings of $1.25 per share, reflecting an increase of 26.3% compared to the same period last

Last Friday, the three major Wall Street indexes closed a winning week. The Nasdaq Composite, the S&P 500 and the Dow Jones Industrial Average gained 5.2%, 3.6% and 3%, respectively.

Wall Street’s

In the latest close session, Abercrombie & Fitch (ANF) was down 3.04% at $108.82. The stock's change was less than the S&P 500's daily gain of 0.65%. Meanwhile, the Dow gained 0.13%, and the Nasdaq

Cadence Design Systems CDNS shares have fallen 12.9% in the past month even though the company delivered double-digit revenue and earnings growth in the second quarter.

Image Source: Zacks

Looking for broad exposure to the Energy - Exploration segment of the equity market? You should consider the iShares U.S. Oil & Gas Exploration & Production ETF (IEO), a passively managed exchange

The second-quarter 2026 reporting season is gathering pace, and the spotlight is shifting to the insurance industry. Several major S&P 500 insurers, including Marsh, AON and The Hartford, have

Merck MRK reported an adjusted loss of 13 cents per share for the second quarter of 2026, narrower than the Zacks Consensus Estimate of a loss of 26 cents. In the year-ago quarter, the company

Viasat, Inc. VSAT reported mixed first-quarter fiscal 2027 results, wherein the top line missed the Zacks Consensus Estimate but the bottom line beat the same.The company reported a year-over-year

IonQ, Inc. IONQ reported an adjusted loss of 33 cents per share for the second quarter of 2026, wider than the year-ago loss of 8 cents. The figure missed the Zacks Consensus Estimate by 13.8%.

Immunocore Holdings plc IMCR incurred a loss of 2 cents per share in the second quarter of 2026, wider than the Zacks Consensus Estimate of a loss of 1 cent per share. In the year-ago quarter, the

Novavax NVAX incurred a loss of 32 cents per share in the second quarter of 2026, narrower than the Zacks Consensus Estimate of a loss of 36 cents. In the year-ago quarter, the company had recorded

Wall Street closed higher on Friday as weak jobs data for July raised hope that the Federal Reserve may hold interest rates steady for longer. The Nasdaq Composite, the S&P 500 and the Dow ended in

The second-quarter earnings season has given investors a clearer view of the commercial progress of the three leading U.S.-listed pure-play quantum computing companies, IonQ IONQ, D-Wave Quantum QBT

The Department of Labor reported that the producer price index (PPI) for final products remained unchanged in July. The Zacks Consensus Estimate was for an increase of 0.1%. The metric for July was

The Department of Labor reported that the producer price index (PPI) for final products remained unchanged in July. The Zacks Consensus Estimate was for an increase of 0.1%. The metric for July was